The use of AI in electrocardiograms could reduce hospitalisations for heart failure by 40%

By providing a disease score from ECG results, the project’s ground-breaking approach provides clinicians at healthcare centres with crucial information to make informed decisions on patient treatment and management, with earlier referral to a cardiologist. The project will recruit more than 2,500 European patients with risk factors associated with heart failure to demonstrate the reliability of its algorithm in the early detection of heart failure decompensation.

Under the leadership of Idoven, the FAITHFUL consortium is formed by prominent health organizations, including AstraZeneca Spain, the Servicio Madrileño de Salud (SERMAS), the Fundación para la Investigación Biomédica del Hospital 12 de Octubre, the Fundación para la Investigación Biomédica del Hospital Gregorio Marañón, the Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria, the Institut Català de la Salut, Karolinska Institute, Region Stockholm, MADoPA – Centre Expert en Technologies et Services pour le Maintien en Autonomie à Domicile des Personnes Âgées, and the Estonian Health Insurance Fund. Additionally, FAITHFUL counts on the collaboration of several key external partners, including the Fundación Instituto de Investigación Marqués de Valdecilla (Idival), the Fundación del Ilustre Colegio Oficial de Médicos de Madrid (Fundación ICOMEM), and TIC Salut Social Foundation.

The project is co-funded by EIT Health con 1,7 millones de euros hasta finales de 2025.